These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 5156526

  • 21. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].
    Rajnai H, Bödör C, Reiniger L, Timár B, Csernus B, Szepesi A, Csomor J, Matolcsy A.
    Orv Hetil; 2006 Nov 12; 147(45):2175-9. PubMed ID: 17402211
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Primary and secondary thrombocythemia: apropos of 39 cases].
    Bernadou A, Loo H, Prost RJ, Doumenc J, Zittoun R, Bilski-Pasquier G.
    Sem Hop; 1968 Jun 26; 44(31):2092-100. PubMed ID: 4300454
    [No Abstract] [Full Text] [Related]

  • 24. [Clinical analysis of 185 patients with polycythemia vera].
    Bai J, Shao Z, Jing L, Liu H, Shi J, Zhao M, Fu R, He G, Sun J, Jia H, Qian L, Yang T, Yang C.
    Zhonghua Xue Ye Xue Za Zhi; 2002 Nov 26; 23(11):578-80. PubMed ID: 12482341
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Pyoderma gangrenosum and Vaquez's disease complicated by myelofibrosis. Apropos of a case in a 75-year-old patient].
    Bruet A, Sei JF, Mathé C, Teillet L, Fendler JP.
    Rev Med Interne; 1989 Nov 26; 10(4):349-51. PubMed ID: 2678344
    [No Abstract] [Full Text] [Related]

  • 27. [Rich-marrow "myelofibrosis"].
    Clément F, Meyer S, Binswanger R.
    Schweiz Med Wochenschr; 1971 Dec 11; 101(49):1777-8. PubMed ID: 5140915
    [No Abstract] [Full Text] [Related]

  • 28. [A case of secondary gout associated with myelofibrosis following polycythemia vera (author's transl)].
    Nagai Y, Ikebe K, Ito K, Nishizawa T, Akaoka I, Muranaka M, Horiuchi Y.
    Rinsho Ketsueki; 1978 Mar 11; 19(3):226-33. PubMed ID: 702809
    [No Abstract] [Full Text] [Related]

  • 29. Primary polycythaemia. 3. Studies on the significance of the history of the disease and of the treatment for the development of clones in bone marrow cells.
    Visfeldt J, Franzén S, Nielsen A, Tribukait B.
    Acta Pathol Microbiol Scand A; 1973 Mar 11; 81(2):195-203. PubMed ID: 4734062
    [No Abstract] [Full Text] [Related]

  • 30. Primary thrombocythemia.
    Jamshidi K, Ansari A, Windschitl HE, Swaim WR.
    Geriatrics; 1973 Jan 11; 28(1):121-33. PubMed ID: 4539498
    [No Abstract] [Full Text] [Related]

  • 31. Pathogenetic mechanisms in chronic myeloproliferative disorders: polycythemia vera, essential thrombocythemia, agnogenic myeloid metaplasia, and chronic myelogenous leukemia.
    Tefferi A.
    Semin Hematol; 1999 Jan 11; 36(1 Suppl 2):3-8. PubMed ID: 9930550
    [Abstract] [Full Text] [Related]

  • 32. [Diagnostic and pathogenetic significance of some cytogenetic and cythochemical findings (leukocyte alkaline phosphatase) in systemic hemopathies with myeloproliferative tendencies].
    Cacciola E, Giustolisi R.
    Haematologica; 1970 Jan 11; 55(5):311-32. PubMed ID: 4995787
    [No Abstract] [Full Text] [Related]

  • 33. Polycythemia vera associated with lymphomatous diseases and myeloma.
    Heinle EW, Sarasti HO, Garcia D, Kenny JJ, Westerman MP.
    Arch Intern Med; 1966 Oct 11; 118(4):351-5. PubMed ID: 5925233
    [No Abstract] [Full Text] [Related]

  • 34. Studies on the phagocytic activity of neutrophilic leukocytes.
    Brandt L.
    Scand J Haematol Suppl; 1967 Oct 11; 2():1-126. PubMed ID: 5243720
    [No Abstract] [Full Text] [Related]

  • 35. Post-polycythemia myeloid metaplasia: experience with a large cohort of patients.
    Randi ML, Barbone E, Fabris F, Varotto L, Macri C, Girolami A.
    J Med; 1994 Oct 11; 25(6):363-9. PubMed ID: 7769374
    [Abstract] [Full Text] [Related]

  • 36. [The risk factors for thrombosis, myelofibrosis and leukemia transformation in patients with polycythemia vera].
    Bai J, Xue YP, Ye L, Yao JF, Zhou CL, Qian LS, Yang RC, Li HY, Zhang HY, Shao ZH.
    Zhonghua Xue Ye Xue Za Zhi; 2007 Oct 11; 28(10):685-8. PubMed ID: 18399175
    [Abstract] [Full Text] [Related]

  • 37. Secondary gout associated with chronic myeloproliferative disorders.
    Yu T, Weinreb N, Wittman R, Wasserman LR.
    Semin Arthritis Rheum; 1976 Feb 11; 5(3):247-56. PubMed ID: 1062009
    [No Abstract] [Full Text] [Related]

  • 38. [Polycythemia vera].
    Rorvik TO.
    Tidsskr Nor Laegeforen; 1974 Nov 20; 94(32):2260-3. PubMed ID: 4439383
    [No Abstract] [Full Text] [Related]

  • 39. [Histologic bone marrow findings in polycythemia vera before and after P32 therapy. (At the same time a contribution to the differential diagnosis of the clinical feature "polycythemia")].
    Hauswaldt C, Hunstein W, Uhl N, Doering P.
    Arch Klin Med; 1967 Nov 20; 213(3):219-36. PubMed ID: 5594424
    [No Abstract] [Full Text] [Related]

  • 40. Chromosome abnormalities in the myeloproliferative disorders.
    Dewald GW, Wright PI.
    Semin Oncol; 1995 Aug 20; 22(4):341-54. PubMed ID: 7638632
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.